Thomas J. Schall - Net Worth and Insider Trading

Thomas J. Schall Net Worth

The estimated net worth of Thomas J. Schall is at least $124 Million dollars as of 2024-03-29. Thomas J. Schall is the President and CEO of ChemoCentryx Inc and owns about 2,393,352 shares of ChemoCentryx Inc (CCXI) stock worth over $124 Million. Thomas J. Schall is also the Director of Immuneering Corp and owns about 2,900 shares of Immuneering Corp (IMRX) stock worth over $8,338. Details can be seen in Thomas J. Schall's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas J. Schall has not made any transactions after 2024-03-22 and currently still holds the listed stock(s).

Transaction Summary of Thomas J. Schall

To

Thomas J. Schall Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas J. Schall owns 1 companies in total, including ChemoCentryx Inc () .

Click here to see the complete history of Thomas J. Schall’s form 4 insider trades.

Insider Ownership Summary of Thomas J. Schall

Ticker Comapny Transaction Date Type of Owner
ChemoCentryx Inc 2022-08-04 director & 10 percent owner & President & CEO and Director

Thomas J. Schall Latest Holdings Summary

Thomas J. Schall currently owns a total of 2 stocks. Among these stocks, Thomas J. Schall owns 2,393,352 shares of ChemoCentryx Inc (CCXI) as of August 4, 2022, with a value of $124 Million and a weighting of 99.99%. Thomas J. Schall also owns 2,900 shares of Immuneering Corp (IMRX) as of March 22, 2024, with a value of $8,338 and a weighting of 0.01%.

Latest Holdings of Thomas J. Schall

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CCXI ChemoCentryx Inc 2022-08-04 2,393,352 51.99 124,430,370
IMRX Immuneering Corp 2024-03-22 2,900 2.88 8,338

Holding Weightings of Thomas J. Schall


Thomas J. Schall Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas J. Schall has made a total of 11 transactions in ChemoCentryx Inc (CCXI) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in ChemoCentryx Inc is the sale of 130,000 shares on August 4, 2022, which brought Thomas J. Schall around $7 Million.

According to the SEC Form 4 filings, Thomas J. Schall has made a total of 1 transactions in Immuneering Corp (IMRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immuneering Corp is the acquisition of 2,900 shares on March 22, 2024, which cost Thomas J. Schall around $7,395.

Insider Trading History of Thomas J. Schall

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas J. Schall Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas J. Schall Ownership Network

Ownership Network List of Thomas J. Schall

No Data

Ownership Network Relation of Thomas J. Schall


Thomas J. Schall Owned Company Details

What does ChemoCentryx Inc do?

Who are the key executives at ChemoCentryx Inc?

Thomas J. Schall is the director & 10 percent owner & President & CEO and Director of ChemoCentryx Inc. Other key executives at ChemoCentryx Inc include SVP Finance & CFO & Secretary Susan M Kanaya , SVP & Finance & Acctg Officer Yi Ching Yau , and 10 percent owner Vifor (international) Ltd .

ChemoCentryx Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChemoCentryx Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ChemoCentryx Inc Insider Transactions

No Available Data

Thomas J. Schall Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas J. Schall. You might contact Thomas J. Schall via mailing address: 850 Maude Avenue Mountain View Ca 94043.

Discussions on Thomas J. Schall

No discussions yet.